GeneDx (WGS) Insider Trading & Ownership $37.14 -0.58 (-1.54%) (As of 09/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GeneDx (NASDAQ:WGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.10%Number OfInsiders Buying(Last 12 Months)7Amount OfInsider Buying(Last 12 Months)$4.21 MNumber OfInsiders Selling(Last 12 Months)19Amount OfInsider Selling(Last 12 Months)$24.82 M Get WGS Insider Trade Alerts Want to know when executives and insiders are buying or selling GeneDx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address WGS Insider Buying and Selling by Quarter Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. GeneDx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/9/2024Katherine StuelandCEOSell3,639$33.33$121,287.87 9/9/2024Kevin FeeleyCFOSell895$33.33$29,830.35 9/3/2024Kevin FeeleyCFOSell262$31.71$8,308.02 8/19/2024Opko Health, Inc.Major ShareholderSell50,000$34.49$1,724,500.00 8/15/2024Opko Health, Inc.Major ShareholderSell39,824$33.08$1,317,377.92 8/12/2024Opko Health, Inc.Major ShareholderSell59,787$33.95$2,029,768.65 Bill Gates’ Next Big Thing: “Exegesis AI” (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate8/8/2024Opko Health, Inc.Major ShareholderSell100,000$31.82$3,182,000.00 8/6/2024Opko Health, Inc.Major ShareholderSell12,994$29.35$381,373.90 7/31/2024Opko Health, Inc.Major ShareholderSell88,839$33.50$2,976,106.50 7/29/2024Katherine StuelandCEOSell2,154$33.54$72,245.16 7/29/2024Kevin FeeleyCFOSell274$33.54$9,189.96 7/29/2024Opko Health, Inc.Major ShareholderSell50,000$33.86$1,693,000.00 7/26/2024Opko Health, Inc.Major ShareholderSell60,000$33.85$2,031,000.00 7/24/2024Opko Health, Inc.Major ShareholderSell75,000$33.72$2,529,000.00 7/22/2024Opko Health, Inc.Major ShareholderSell50,000$32.61$1,630,500.00 7/19/2024Opko Health, Inc.Major ShareholderSell25,000$32.29$807,250.00 7/17/2024Opko Health, Inc.Major ShareholderSell25,000$32.93$823,250.00 7/5/2024Opko Health, Inc.Major ShareholderSell36,118$28.24$1,019,972.32 7/3/2024Opko Health, Inc.Major ShareholderSell14,082$28.23$397,534.86 7/1/2024Opko Health, Inc.Major ShareholderSell50,000$26.63$1,331,500.00 6/17/2024Katherine StuelandCEOSell7,683$28.31$217,505.73 6/17/2024Kevin FeeleyCFOSell2,646$28.31$74,908.26 6/10/2024Katherine StuelandCEOSell2,652$24.92$66,087.84 6/10/2024Kevin FeeleyCFOSell895$24.92$22,303.40 6/3/2024Casdin Capital, LlcDirectorBuy100,000$20.82$2,082,000.00 5/28/2024Casdin Capital, LlcDirectorBuy18,304$20.61$377,245.44 5/23/2024Casdin Capital, LlcDirectorBuy7,500$19.59$146,925.00 5/13/2024Casdin Capital, LlcDirectorBuy50,000$23.31$1,165,500.00 4/29/2024Katherine StuelandCEOSell6,325$11.04$69,828.00 4/29/2024Kevin FeeleyCFOSell1,104$11.04$12,188.16 3/18/2024Kareem SaadInsiderSell2,008$10.59$21,264.72 3/18/2024Katherine StuelandCEOSell8,559$10.59$90,639.81 3/18/2024Kevin FeeleyCFOSell3,253$10.59$34,449.27 3/4/2024Casdin Capital, LlcDirectorBuy40,000$8.74$349,600.00 1/22/2024Kareem SaadInsiderSell193$3.24$625.32 1/3/2024Kareem SaadInsiderSell105$2.58$270.90 12/18/2023Kareem SaadInsiderSell1,700$2.16$3,672.00 12/18/2023Katherine StuelandCEOSell11,734$2.16$25,345.44 12/18/2023Kevin FeeleyCFOSell2,948$2.16$6,367.68 12/4/2023Kevin FeeleyCFOSell270$1.77$477.90 Bill Gates’ Next Big Thing: “Exegesis AI” (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate11/16/2023Jason RyanChairmanBuy56,742$1.27$72,062.34 11/8/2023Richard C Pfenniger JrDirectorBuy10,000$1.49$14,900.00 10/20/2023Kareem SaadInsiderSell164$3.44$564.16 10/17/2023Jason RyanChairmanSell42$3.19$133.98 10/3/2023Kareem SaadInsiderSell85$3.56$302.60 9/18/2023Kareem SaadInsiderSell1,580$4.16$6,572.80 9/18/2023Katherine StuelandCEOSell10,752$4.16$44,728.32 9/18/2023Kevin FeeleyCFOSell2,742$4.16$11,406.72 (Data available from 1/1/2013 forward) WGS Insider Trading Activity - Frequently Asked Questions Who is on GeneDx's Insider Roster? The list of insiders at GeneDx includes Anthony Prentice, Casdin Capital, Llc, Daniel Emmett Clark, Eric Schadt, Isaac Ro, James Coffin, Jason Ryan, Kareem Saad, Karen Ann White, Katherine Stueland, Keith A Meister, Kevin Feeley, Opko Health, Inc., Richard C Pfenniger Jr, Richard Miao, Shawn Assad, and Tactical Opportunit Blackstone. Learn more on insiders at WGS. What percentage of GeneDx stock is owned by insiders? 28.10% of GeneDx stock is owned by insiders. Learn more on WGS's insider holdings. Which GeneDx insiders have been buying company stock? The following insiders have purchased WGS shares in the last 24 months: Casdin Capital, Llc ($4,121,270.44), Jason Ryan ($72,062.34), Katherine Stueland ($99,988.02), and Richard C Pfenniger Jr ($69,900.00). How much insider buying is happening at GeneDx? Insiders have purchased a total of 298,157 WGS shares in the last 24 months for a total of $4,363,220.80 bought. Which GeneDx insiders have been selling company stock? The following insiders have sold WGS shares in the last 24 months: Jason Ryan ($1,212.42), Kareem Saad ($47,405.88), Karen Ann White ($31,366.48), Katherine Stueland ($877,917.64), Keith A Meister ($2,715,741.60), Kevin Feeley ($264,662.57), and Opko Health, Inc. ($23,874,134.15). How much insider selling is happening at GeneDx? Insiders have sold a total of 1,054,822 GeneDx shares in the last 24 months for a total of $27,812,440.74 sold. More Insider Trading Tools from MarketBeat Related Companies: SGRY Insider Buying HIMS Insider Buying GH Insider Buying LFST Insider Buying VCYT Insider Buying BTSG Insider Buying ADUS Insider Buying PRVA Insider Buying NHC Insider Buying FTRE Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Matador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock3 Small Cap Stocks Insiders Are Actively Buying This page (NASDAQ:WGS) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredI’m giving you the name of this investment for freeNow that the Federal Reserve lowered interest rates, this investment could easily go up 50%.Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding GeneDx Holdings Corp. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.